Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3681797012 | Product containing precisely paromomycin (as paromomycin sulfate) 250 milligram/1 each conventional release oral capsule (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3681798019 | Paromomycin (as paromomycin sulfate) 250 mg oral capsule | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely paromomycin (as paromomycin sulfate) 250 milligram/1 each conventional release oral capsule (clinical drug) | Is a | Product containing paromomycin (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely paromomycin (as paromomycin sulfate) 250 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | Paromomycin sulfate | false | Inferred relationship | Some | ||
| Product containing precisely paromomycin (as paromomycin sulfate) 250 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | Substance with aminoglycoside structure and antibacterial mechanism of action (substance) | false | Inferred relationship | Some | ||
| Product containing precisely paromomycin (as paromomycin sulfate) 250 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | Antiparasite agent | false | Inferred relationship | Some | ||
| Product containing precisely paromomycin (as paromomycin sulfate) 250 milligram/1 each conventional release oral capsule (clinical drug) | Has manufactured dose form | Capsule | false | Inferred relationship | Some | ||
| Product containing precisely paromomycin (as paromomycin sulfate) 250 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | Bactericide | false | Inferred relationship | Some | ||
| Product containing precisely paromomycin (as paromomycin sulfate) 250 milligram/1 each conventional release oral capsule (clinical drug) | Has manufactured dose form | Oral capsule | true | Inferred relationship | Some | ||
| Product containing precisely paromomycin (as paromomycin sulfate) 250 milligram/1 each conventional release oral capsule (clinical drug) | Is a | Product manufactured as oral dose form (product) | false | Inferred relationship | Some | ||
| Product containing precisely paromomycin (as paromomycin sulfate) 250 milligram/1 each conventional release oral capsule (clinical drug) | Is a | Product containing paromomycin in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely paromomycin (as paromomycin sulfate) 250 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | Paromomycin sulfate | false | Inferred relationship | Some | 1 | |
| Product containing precisely paromomycin (as paromomycin sulfate) 250 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Paromomycin | true | Inferred relationship | Some | 1 | |
| Product containing precisely paromomycin (as paromomycin sulfate) 250 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator value | 250 | false | Inferred relationship | Some | 1 | |
| Product containing precisely paromomycin (as paromomycin sulfate) 250 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely paromomycin (as paromomycin sulfate) 250 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator value | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | 1 | |
| Product containing precisely paromomycin (as paromomycin sulfate) 250 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | Capsule (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Product containing precisely paromomycin (as paromomycin sulfate) 250 milligram/1 each conventional release oral capsule (clinical drug) | Has unit of presentation | Capsule (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely paromomycin (as paromomycin sulfate) 250 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | Paromomycin sulfate | true | Inferred relationship | Some | 1 | |
| Product containing precisely paromomycin (as paromomycin sulfate) 250 milligram/1 each conventional release oral capsule (clinical drug) | Count of base of active ingredient | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | ||
| Product containing precisely paromomycin (as paromomycin sulfate) 250 milligram/1 each conventional release oral capsule (clinical drug) | Is a | Product containing only paromomycin in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing precisely paromomycin (as paromomycin sulfate) 250 milligram/1 each conventional release oral capsule (clinical drug) | Plays role | Antibacterial therapeutic role (role) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR